Related Experiment Video
Updated: Oct 25, 2025

Real-Time Measurement of the Mitochondrial Bioenergetic Profile of Neutrophils
Published on: June 2, 2023
Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential
Wen-Cheng Zhou1, Jiao Qu2, Sheng-Yang Xie1
1Department of Pharmacy, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou 310006, China.
Mitochondrial dysfunction contributes to chronic lung diseases like COPD, pulmonary fibrosis, and asthma by disrupting cellular processes. Targeting these dysfunctional mitochondria offers potential therapeutic strategies for respiratory conditions.
Area of Science:
- Cellular Biology
- Mitochondrial Biology
- Respiratory Medicine
Background:
- Mitochondria are vital for cellular energy and signaling, requiring strict homeostasis.
- Mitochondrial homeostasis involves membrane potential, calcium balance, DNA integrity, and mitophagy.
- Dysfunction disrupts these processes, leading to reactive oxygen species, DNA damage, and impaired mitophagy.
Purpose of the Study:
- To review the impact of mitochondrial dysfunction on cellular processes in chronic respiratory diseases.
- To explore the role of mitochondrial dysregulation in the pathogenesis of COPD, pulmonary fibrosis, and asthma.
- To identify potential therapeutic targets within dysfunctional mitochondria for lung diseases.
Main Methods:
- Comprehensive literature review of mitochondrial dysfunction in chronic respiratory diseases.
- Analysis of cellular mechanisms linking mitochondrial dysregulation to disease pathogenesis.
- Synthesis of current understanding of mitochondrial roles in oxidative stress, inflammation, apoptosis, senescence, and metabolic reprogramming.
Main Results:
- Mitochondrial dysfunction drives key pathological cellular processes including oxidative stress, inflammasome activation, apoptosis, senescence, and metabolic reprogramming.
- These dysregulated cellular processes are implicated in the development and progression of chronic obstructive pulmonary disease, pulmonary fibrosis, and asthma.
- Evidence links specific mitochondrial defects to the pathophysiology of major chronic lung diseases.
Conclusions:
- Mitochondrial dysfunction is a critical factor in the pathogenesis of chronic respiratory diseases.
- Understanding these mechanisms provides insights into disease development.
- Targeting dysfunctional mitochondria presents a promising therapeutic avenue for treating chronic lung diseases.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction
Mitochondria
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

